IMC Chicago
GSK icon

IMC Chicago’s GSK GSK Stock Holding History

IMC Chicago’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.6M Sell
191,400
-6,800
-3% -$368K ﹤0.01% 1219
2025
Q4 		$9.72M Buy
198,200
+15,200
+8% +$709K ﹤0.01% 1245
2025
Q3 		$7.9M Sell
183,000
-20,300
-10% -$793K ﹤0.01% 1284
2025
Q2 		$7.81M Sell
203,300
-42,300
-17% -$1.62M ﹤0.01% 1141
2025
Q1 		$9.51M Sell
245,600
-158,800
-39% -$5.81M 0.01% 902
2024
Q4 		$13.7M Buy
404,400
+234,100
+137% +$8.43M 0.01% 769
2024
Q3 		$6.96M Buy
170,300
+18,700
+12% +$765K ﹤0.01% 988
2024
Q2 		$5.84M Sell
151,600
-28,600
-16% -$1.2M ﹤0.01% 1002
2024
Q1 		$7.73M Sell
180,200
-8,900
-5% -$367K ﹤0.01% 805
2023
Q4 		$7.01M Buy
189,100
+23,300
+14% +$836K ﹤0.01% 767
2023
Q3 		$6.01M Buy
165,800
+137,400
+484% +$4.88M 0.01% 693
2023
Q2 		$1.01M Sell
28,400
-49,800
-64% -$1.79M ﹤0.01% 1053
2023
Q1 		$2.78M Sell
78,200
-119,200
-60% -$4.17M ﹤0.01% 764
2022
Q4 		$6.94M Buy
197,400
+8,600
+5% +$286K 0.01% 531
2022
Q3 		$5.56M Buy
188,800
+104,800
+125% +$3.97M 0.01% 553
2022
Q2 		$4.57M Buy
84,000
+44,240
+111% +$2.44M 0.01% 564
2022
Q1 		$2.17M Buy
+39,760
New +$2.16M ﹤0.01% 759
2021
Q2 		– Sell
-14,160
Closed -$632K – 1137
2021
Q1 		$632K Sell
14,160
-14,800
-51% -$672K ﹤0.01% 927
2020
Q4 		$1.33M Sell
28,960
-6,160
-18% -$283K ﹤0.01% 800
2020
Q3 		$1.65M Buy
35,120
+20,080
+134% +$1.01M ﹤0.01% 622
2020
Q2 		$767K Sell
15,040
-19,840
-57% -$1.02M ﹤0.01% 752
2020
Q1 		$1.65M Buy
+34,880
New +$1.86M ﹤0.01% 542

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

IMC Chicago's GSK Position: Q4 2025 in Review

IMC Chicago sold out of GSK (GSK) in Q4 2025, closing a stake of 41,319 shares — an estimated $1.93M sold.

IMC Chicago first reported a position in GSK in Q3 2020 and held it in 8 quarters. The position peaked at $2.31M in Q4 2022. 995 funds tracked by Wall St. Rank hold GSK as of Q4 2025.

  • IMC Chicago reported no remaining GSK position as of Q4 2025 after selling out during the quarter.
  • IMC Chicago sold 41,319 GSK shares in Q4 2025, an estimated $1.93M.
  • IMC Chicago first reported a position in GSK in Q3 2020 and held it in 8 quarters.
  • IMC Chicago's GSK position peaked at $2.31M in Q4 2022.
  • 995 funds tracked by Wall St. Rank held GSK as of Q4 2025.

Based on IMC Chicago's 13F filing for Q4 2025, filed 29 Jan 2026.